Filed: 8/8/2024ACC: 0001123292-24-000213
📋 What this filing means
ATHYRIUM CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $33.54M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$33.54M
Total AUM (reported)
42.19M
Total Shares
Allocation by class
NOTE 1.500% 4/1$22.23M66.3%
COM NEW$7.21M21.5%
COM$4.10M12.2%
Portfolio Concentration
Top 3$33.54M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 42.19M
Sole
Full voting authority
12.19M
shares
% of voting shares28.9%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
30M
shares
% of voting shares71.1%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeNone · 71.1% of voting shares
Institutional Holdings3
Rows:
COHERUS BIOSCIENCES INC
SOLEShares30M
TypePRN
Market value$22.23M
66.28%
Sole
0.00
Shared
0.00
None
30M
Biora Therapeutics Inc.
SOLEShares10.93M
TypeSH
Market value$7.21M
21.51%
Sole
10.93M
Shared
0.00
None
0.00
PUMA BIOTECHNOLOGY INC
SOLEShares1.26M
TypeSH
Market value$4.10M
12.21%
Sole
1.26M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
COHERUS BIOSCIENCES INCSOLE | NOTE 1.500% 4/1 | 30M | PRN | $22.23M 66.28% | 0.00 | 0.00 | 30M |
Biora Therapeutics Inc.SOLE | COM NEW | 10.93M | SH | $7.21M 21.51% | 10.93M | 0.00 | 0.00 |
PUMA BIOTECHNOLOGY INCSOLE | COM | 1.26M | SH | $4.10M 12.21% | 1.26M | 0.00 | 0.00 |